Resolution Therapeutics is a biotechnology company developing macrophage cell therapy to treat inflammatory organ disease. The company was founded following a productive collaboration between Edinburgh’s Centre for Regenerative Medicine, the Scottish National Blood Transfusion Service, and Syncona Investment Management Limited. The company is based in the Centre for Regenerative Medicine on the Edinburgh Royal Infirmary Campus, and is backed by Syncona.
Our initial focus is in chronic liver disease. It is the only chronic disease still on the rise in western countries, and affects millions of people worldwide. Unfortunately, only supportive therapies are currently available. For patients with end-stage liver disease (cirrhosis) the only therapeutic option is liver transplantation, a complex surgical procedure limited by complications and a shortage of donors. At Resolution Therapeutics, we are developing a macrophage cell therapy product to treat patients at risk of liver decompensation, thus helping them avoid the need for a liver transplant.
Company Details
- Employees
- 76
- Founded
- -
- Address
- 5 Little France Drive, Centre For Regenerative Medicine,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://resolution-tx.com/
- HQ
- Edinburgh, Scotland
Resolution Therapeutics Questions
Resolution Therapeutics's website is https://resolution-tx.com/
Resolution Therapeutics's LinkedIn profile is https://uk.linkedin.com/company/resolution-therapeutics
Resolution Therapeutics has
76 employees.
View email and phone details for 76
employees at Resolution Therapeutics.
Resolution Therapeutics's industry is
Biotechnology Research
Resolution Therapeutics's top competitors are
Purespring Therapeutics,
Kailera Therapeutics,
Triveni Bio,
Quell Therapeutics,
Enara Bio,
Autolus Therapeutics,
Aviadobio,
Loqus23 Therapeutics Ltd,
Syncona Limited,
Cell And Gene Therapy Catapult.
Resolution Therapeutics's categories are Biotechnology Research
Resolution Therapeutics's founding year is 2020
